One of the biggest potential impacts is to the supply chain, says John Ransom, managing director of healthcare research. “We source a lot of [active pharmaceutical ingredients] from India and China.”
Recorded February 25, 2020
Markets & Investing July 01, 2022 Review the latest portfolio strategy commentary from Mike Gibbs,...
Markets & Investing July 01, 2022 Where can investors turn when the markets are a riddle? Raymond James...
Economy & Policy July 01, 2022 Chief Economist Eugenio J. Alemán discusses current economic...